Evidence map›Paper›PMID 35053434›Full record

ArticleCancers2022

Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT.

Patrick W Mihatsch, Matthias Beissert, Martin G Pomper, Thorsten A Bley, Anna K Seitz, Hubert Kübler, Andreas K Buck, Steven P Rowe, Sebastian E Serfling, Philipp E Hartrampf and 1 more

Abstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. [Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Article
  2. Association of [Diagnostics (Basel, Switzerland) · 2025
    Article
  3. The superior detection rate of total-body [European journal of nuclear medicine and molecular imaging · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Patrick W MihatschDepartment of Diagnostic and Interventional Radiology, University Hospital of Würzburg, 97080 Würzburg, Germany.
Matthias BeissertDepartment of Diagnostic and Interventional Radiology, University Hospital of Würzburg, 97080 Würzburg, Germany.
Martin G PomperThe Russell H. Morgan Department of Radiology and Radiological Science, Division of Nuclear Medicine and Molecular Imaging, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Thorsten A BleyDepartment of Diagnostic and Interventional Radiology, University Hospital of Würzburg, 97080 Würzburg, Germany.
Anna K SeitzDepartment of Urology and Paediatric Urology, University Hospital of Würzburg, 97080 Würzburg, Germany.
Hubert KüblerDepartment of Urology and Paediatric Urology, University Hospital of Würzburg, 97080 Würzburg, Germany.
Andreas K BuckDepartment of Nuclear Medicine, University Hospital of Würzburg, 97080 Würzburg, Germany.
Steven P RoweThe Russell H. Morgan Department of Radiology and Radiological Science, Division of Nuclear Medicine and Molecular Imaging, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.ORCID 0000-0003-2897-4694
Sebastian E SerflingDepartment of Nuclear Medicine, University Hospital of Würzburg, 97080 Würzburg, Germany.
Philipp E HartrampfDepartment of Nuclear Medicine, University Hospital of Würzburg, 97080 Würzburg, Germany.ORCID 0000-0001-5622-9849
Rudolf A WernerDepartment of Nuclear Medicine, University Hospital of Würzburg, 97080 Würzburg, Germany.

Funding

IZKF Würzburg Z-02/85
6 · The paper itself

Abstract

Prostate-specific membrane antigen (PSMA)-directed positron emission tomography/computed tomography (PET/CT) is increasingly utilized for staging of men with prostate cancer (PC). To increase interpretive certainty, the standardized PSMA reporting and data system (RADS) has been proposed. Using PSMA-RADS, we characterized lesions in 18 patients imaged with

Indexed as

18F-PSMA-1007PET/CTprostate cancerPSMA-RADSstagingstandardized reporting system

Identifiers

PMID35053434
PMCPMC8773894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.